Resultados globales: 5 registros encontrados en 0.01 segundos.
Artículos, Encontrados 5 registros
Artículos Encontrados 5 registros  
1.
13 p, 1.5 MB Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey / Hüls, Anke (Department of Epidemiology and Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA) ; Costa, Alberto C.S. (Departments of Pediatrics and of Psychiatry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA) ; Dierssen, Mara (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; Baksh, R. Asaad (The London Down Syndrome (LonDownS) Consortium, London, United Kingdom) ; Bargagna, Stefania (Fondazione Stella Maris IRCCS, Pisa, Italy) ; Baumer, Nicole T. (Harvard Medical School) ; Brandão, Ana Claudia (Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil) ; Carfi, Angelo (Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy) ; Carmona Iragui, María (Institut d'Investigació Biomèdica Sant Pau) ; Chicoine, Brian Allen (Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL, USA) ; Ghosh, Sujay (Cytogenetics and Genomics Reserach Unit. Department of Zoology, University of Calcutta.Kolkata. West Bengal, India) ; Lakhanpaul, Monica (Whttington NHS Trust, London, United Kingdom; Down Syndrome Medical Interest Group, London, United Kingdom) ; Manso, Coral (CM: DOWN ESPAÑA, Madrid, Spain) ; Mayer, Miguel-Angel (Institut Hospital del Mar d'Investigacions Mèdiques) ; Ortega, Maria del Carmen (Hospital Universitario 12 de Octubre (Madrid)) ; de Asua, Diego Real (Instituto de Investigación Hospital Universitario de la Princesa) ; Rebillat, Anne-Sophie (Institut Jérôme Lejeune, Paris, France) ; Russell, Lauren Ashley (Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA) ; Sgandurra, Giuseppina (Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy) ; Valentini, Diletta (Pediatric Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy) ; Sherman, Stephanie L. (Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia, USA) ; Strydom, Andre (South London and the Maudsley NHS Foundation Trust) ; Universitat Autònoma de Barcelona
Health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may impact the clinical course of COVID-19. The T21RS COVID-19 Initiative launched an international survey for clinicians or caregivers on patients with COVID-19 and DS. [...]
2021 - 10.1016/j.eclinm.2021.100769
EClinicalMedicine, february 2021  
2.
26 p, 562.2 KB Potential Role of Olive Oil Phenolic Compounds in the Prevention of Neurodegenerative Diseases / Rodríguez-Morató, Jose (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Xicota, Laura (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ; Fitó, Montse (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farré Albaladejo, Magí (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Dierssen, Mara (CIBER de Enfermedades Raras (CIBERER), Barcelona) ; de la Torre, Rafael (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut)
Adherence to the Mediterranean Diet (MD) has been associated with a reduced incidence of neurodegenerative diseases and better cognitive performance. Virgin olive oil, the main source of lipids in the MD, is rich in minor phenolic components, particularly hydroxytyrosol (HT). [...]
2015 - 10.3390/molecules20034655
Molecules, Vol. 20 (march 2015) , p. 4655-4680  
3.
9 p, 894.2 KB VNTR-DAT1 and COMTVal158Met Genotypes Modulate Mental Flexibility and Adaptive Behavior Skills in Down Syndrome / del Hoyo, Laura (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Xicota, Laura (Institut Hospital del Mar d'Investigacions Mèdiques) ; Langohr, Klaus (Institut Hospital del Mar d'Investigacions Mèdiques) ; Sánchez-Benavides, Gonzalo (Institut Hospital del Mar d'Investigacions Mèdiques) ; de Sola, Susana (Institut Hospital del Mar d'Investigacions Mèdiques) ; Cuenca-Royo, Aida (Institut Hospital del Mar d'Investigacions Mèdiques) ; Rodriguez, Joan (Institut Hospital del Mar d'Investigacions Mèdiques) ; Rodríguez-Morató, Jose (Institut Hospital del Mar d'Investigacions Mèdiques) ; Farré Albaladejo, Magí (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Dierssen, Mara (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; de la Torre, Rafael (Institut Hospital del Mar d'Investigacions Mèdiques)
Down syndrome (DS) is an aneuploidy syndrome that is caused by trisomy for human chromosome 21 resulting in a characteristic cognitive and behavioral phenotype, which includes executive functioning and adaptive behavior difficulties possibly due to prefrontal cortex (PFC) deficits. [...]
2016 - 10.3389/fnbeh.2016.00193
Frontiers in Behavioral Neuroscience, Vol. 10 (october 2016)  
4.
16 p, 1020.6 KB Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction / Dierssen, Mara (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Gratacòs i Mayora, Mònica (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Sahún, Ignasi (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Martín, Miguel (Universitat Pompeu Fabra. Àrea de Neurofarmacologia) ; Gallego, Xavier (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Amador-Arjona, Alehandro (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Martínez de Lagrán María (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Murtra, Patricia (Universitat Pompeu Fabra. Àrea de Neurofarmacologia) ; Martí, Eulalia (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Pujana, Miguel A. (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Ferrer, Isidre (Hospital Prínceps d'Espanya. Àrea de neuropatologia) ; Dalfo Capella, Esther (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Martínez-Cué, Carmen (Universidad de Cantabria. Departamento de Psicologia y Farmacologia) ; Flórez, Jesús (Universidad de Cantabria. Departamento de Psicologia y Farmacologia) ; Torres-Peraza, Jesús F. (Universitat de Barcelona. Departament de Biologia Cel·lular i Anatomia Patològica) ; Alberch i Vié, Jordi (Universitat de Barcelona. Departament de Biologia Cel·lular i Anatomia Patològica) ; Maldonado, Rafael (Universitat Pompeu Fabra. Àrea de Neurofarmacologia) ; Fillat, Cristina (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center) ; Estivill, Xavier (Biomedical Research Park. Genes and Disease Program, Genomic Regulation Center)
Accumulating evidence has suggested that neurotrophins participate in the pathophysiology of mood disorders. We have developed transgenic mice overexpressing the full-length neurotrophin-3 receptor TrkC (TgNTRK3) in the central nervous system. [...]
2006 - 10.1016/j.nbd.2006.07.015
Neurobiology of disease, Vol. 24, Num. 2 (2006) , p. 403-18  
5.
14 p, 1.0 MB A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials / Sola, Susana de (Institut Hospital del Mar d'Investigacions Mèdiques) ; Torre Fornell, Rafael de la (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición) ; Sánchez-Benavides, Gonzalo (Institut Hospital del Mar d'Investigacions Mèdiques) ; Benejam, Bessy (Fundació Catalana Síndrome de Down) ; Cuenca-Royo, Aida (Institut Hospital del Mar d'Investigacions Mèdiques) ; Hoyo, Laura del (Institut Hospital del Mar d'Investigacions Mèdiques) ; Rodríguez, Joan (Institut Hospital del Mar d'Investigacions Mèdiques) ; Catuara-Solarz, Silvina (Centre de Regulació Genòmica) ; Sánchez-Gutiérrez, Judit (Fundació Espai Salut (Barcelona)) ; Dueñas-Espin, Ivan (Institut Hospital del Mar d'Investigacions Mèdiques) ; Hernandez, Gimena (Institut Hospital del Mar d'Investigacions Mèdiques) ; Peña-Casanova, Jordi (Institut Hospital del Mar d'Investigacions Mèdiques) ; Langohr, Klaus (Institut Hospital del Mar d'Investigacions Mèdiques) ; Videla, Sebastián (Fundació Catalana Síndrome de Down) ; Blehaut, Henry (Fondation Jérôme Lejeune (Paris, França)) ; Farré Albaladejo, Magí (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Dierssen, Mara (Centro de Investigación Biomédica en Red de Enfermedades Raras) ; TESDAD Study Group ; Universitat Autònoma de Barcelona
Abstract: The recent prospect of pharmaceutical interventions for cognitive impairment of Down syndrome (DS) has boosted a number of clinical trials in this population. However, running the trials has raised some methodological challenges and questioned the prevailing methodology used to evaluate cognitive functioning of DS individuals. [...]
2015 - 10.3389/fpsyg.2015.00708
Frontiers in psychology, Vol. 6 Núm. 708 (June 2015)  

Vea también: autores con nombres similares
2 Dierssen, M
1 Dierssen, M.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.